The Role of Probiotic in Reducing Hepatic Inflammation Among NAFLD Patients: an Evidence-Based Case Report

The Role of Probiotic in Reducing Hepatic Inflammation Among NAFLD Patients: an Evidence-Based Case Report

Aim: to know the effectiveness of probiotic in reducing hepatic inflammation among non-alcoholic fatty liver disease (NAFLD) patients. Methods: we performed literature searching regarding the potential role of probiotic in reducing hepatic inflammation among NAFLD patients. Results: six articles wer...

Full description

Bibliographic Details
Main Authors:	Alvin Nursalim, Ummi Ulfah Madina, Cosmas Rinaldi A Lesmana
Format:	Article
Language:	English
Published:	Interna Publishing 2017-02-01
Series:	Acta Medica Indonesiana
Subjects:	non-alcoholic fatty liver disease NAFLD probiotic inflammation
Online Access:	http://www.actamedindones.org/index.php/ijim/article/view/265

Similar Items

The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD
by: Brandon J. Perumpail, et al.
Published: (2019-02-01)

Treatments for NAFLD: State of Art
by: Alessandro Mantovani, et al.
Published: (2021-02-01)

An Update on the Efficacy and Functionality of Probiotics for the Treatment of Non-Alcoholic Fatty Liver Disease
by: Mingfei Yao, et al.
Published: (2021-05-01)

Non Alcoholic Fatty Liver Disease (NAFLD): The Search for a Cure
by: Alabagi Abdulla, et al.
Published: (2016-04-01)

Probiotics and Prebiotics as a Strategy for Non-Alcoholic Fatty Liver Disease, a Narrative Review
by: Valentina Castillo, et al.
Published: (2021-07-01)

Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of Ceramides in NAFLD
by: Annelise M. Poss, et al.
Published: (2020-07-01)

Mineralocorticoid receptor modulation by dietary sodium influences NAFLD development in mice
by: Daniel Cabrera, et al.
Published: (2021-09-01)

Bone Morphogenetic Protein-8B Expression is Induced in Steatotic Hepatocytes and Promotes Hepatic Steatosis and Inflammation In Vitro
by: Abdo Mahli, et al.
Published: (2019-05-01)

Soybean Oil-Derived Poly-Unsaturated Fatty Acids Enhance Liver Damage in NAFLD Induced by Dietary Cholesterol
by: Janin Henkel, et al.
Published: (2018-09-01)

The Effect of Licorice and Probiotics on Nonalcoholic Fatty Liver Disease (NAFLD): A Systematic Review
by: Pouya Rostamizadeh, et al.
Published: (2019-12-01)

Combination of Probiotics and Polysaccharide Alleviates Hepatic Steatosis via Gut Microbiota Modulation and Insulin Resistance Improvement in High Fat-Induced NAFLD Mice
by: Wei Wang, et al.
Published: (2020-04-01)

Circulating Phospholipid Patterns in NAFLD Patients Associated with a Combination of Metabolic Risk Factors
by: Shilpa Tiwari-Heckler, et al.
Published: (2018-05-01)

Biochemical and molecular-genetic indicators of inflammation and apoptosis in liver cirrhosis as an outcome of the progression of non-alcoholic steatohepatitis
by: I V Kurbatova, et al.
Published: (2019-04-01)

Overlapping Clinical Features Between NAFLD and Metabolic Syndrome in Children
by: Anna Alisi, et al.
Published: (2014-05-01)

The Number of Liver Galectin-3 Positive Cells Is Dually Correlated with NAFLD Severity in Children
by: Felipe Leite de Oliveira, et al.
Published: (2019-07-01)

The Nanocurcumin Reduces Appetite in Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): A Double-Blind Randomized Placebo-Controlled Clinical Trial
by: SSeyed Ali Jazayeri-Tehrani, et al.
Published: (2018-04-01)

NAFLD: Challenges and opportunities to address the public health problem in Latin America
by: Juan Pablo Arab, et al.
Published: (2021-09-01)

Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
by: Saeede Saadati, et al.
Published: (2019-07-01)

Depression and Cognitive Impairment—Extrahepatic Manifestations of NAFLD and NASH
by: Martina Colognesi, et al.
Published: (2020-07-01)

Classification of Early Stages of NAFLD Based on Dual Diagnostic Methods
by: Iulian Secrieru, et al.
Published: (2015-11-01)

Effect of probiotic supplementation in nonalcoholic steatohepatitis patients: PROBILIVER TRIAL protocol
by: Amanda Souza Silva-Sperb, et al.
Published: (2019-10-01)

Protective effect of genistein on nonalcoholic fatty liver disease (NAFLD)
by: Xin Xin, et al.
Published: (2019-09-01)

Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants
by: Clémence Rives, et al.
Published: (2020-12-01)

Iron in Child Obesity. Relationships with Inflammation and Metabolic Risk Factors
by: Dominique Bouglé, et al.
Published: (2013-06-01)

Dietary fat stimulates development of NAFLD more potently than dietary fructose in Sprague–Dawley rats
by: Victoria Svop Jensen, et al.
Published: (2018-01-01)

Plasma Levels of Homocysteine and Cysteine Increased in Pediatric NAFLD and Strongly Correlated with Severity of Liver Damage
by: Anna Pastore, et al.
Published: (2014-11-01)

Insulin treatment improves liver histopathology and decreases expression of inflammatory and fibrogenic genes in a hyperglycemic, dyslipidemic hamster model of NAFLD
by: Victoria Svop Jensen, et al.
Published: (2021-02-01)

Risk of reduced platelet counts in patients with nonalcoholic fatty liver disease (NAFLD): a prospective cohort study
by: Fang Liu, et al.
Published: (2018-09-01)

Hepatic expression of Yin Yang 1 (YY1) is associated with the non-alcoholic fatty liver disease (NAFLD) progression in patients undergoing bariatric surgery
by: Xianwen Yuan, et al.
Published: (2018-10-01)

FGF21 regulates hepatic metabolic pathways to improve steatosis and inflammation
by: Helle Keinicke, et al.
Published: (2020-08-01)

The Dietary Replacement of Soybean Oil by Canola Oil Does Not Prevent Liver Fatty Acid Accumulation and Liver Inflammation in Mice
by: Marina Masetto Antunes, et al.
Published: (2020-11-01)

Intestinal Microbiota Modulation in Obesity-Related Non-alcoholic Fatty Liver Disease
by: David Porras, et al.
Published: (2018-12-01)

Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adults
by: Tilman Kühn, et al.
Published: (2018-07-01)

NAFLD as a continuum: from obesity to metabolic syndrome and diabetes
by: Amélio F. Godoy-Matos, et al.
Published: (2020-07-01)

<i>Bifidobacterium breve</i> CNCM I-4035, <i>Lactobacillus paracasei</i> CNCM I-4034 and <i>Lactobacillus rhamnosus</i> CNCM I-4036 Modulate Macrophage Gene Expression and Ameliorate Damage Markers in the Liver of Zucker-Lepr<i><sup>fa/fa</sup></i> Rats
by: Luis Fontana, et al.
Published: (2021-01-01)

Survey on knowledge of non-alcoholic fatty liver disease (NAFLD) among doctors in Sri Lanka: a multicenter study
by: Anne Thushara Matthias, et al.
Published: (2018-08-01)

The Role of the Gut Microbiome and its Derived Mediators in Nonalcoholic Fatty Liver Disease
by: Cosmas Rinaldi A. Lesmana, et al.
Published: (2019-12-01)

The Role of Vitamin E in the Treatment of NAFLD
by: Brandon J. Perumpail, et al.
Published: (2018-09-01)

Probiotic yogurt improves body mass index and fasting insulin levels without affecting serum leptin and adiponectin levels in non-alcoholic fatty liver disease (NAFLD)
by: Safoora Nabavi, et al.
Published: (2015-10-01)

The Effect of Psyllium on Anthropometric Measurements and Liver Enzymes in Overweight or Obese Adults with Nonalcoholic Fatty Liver Disease (NAFLD)
by: Zahra Akbarzadeh, et al.
Published: (2015-12-01)